Israel News Beep | NewsBeep.com
  • News Beep
  • Israel
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Israel News Beep | NewsBeep.com
Israel News Beep | NewsBeep.com
  • News Beep
  • Israel
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

category: Top Stories

13 posts
SSpace
SPCX Logo
Read More

SpaceX AI Pentagon Deal Could Challenge Microsoft, Amazon – SpaceX (NASDAQ:SPCX)

  • July 21, 2026
According to The Wall Street Journal, Elon Musk‘s SpaceX and the Pentagon are discussing a leasing agreement under…
SSpace
RKLB Logo
Read More

Rocket Lab’s Iridium Deal Signals New Era of Space Industry Consolidation – Rocket Lab (NASDAQ:RKLB), Iri

  • July 9, 2026
In June, Rocket Lab agreed to buy all outstanding Iridium shares for $54 each in a cash-and-stock deal…
HHealthcare
What's Going On With Novo Nordisk Stock Thursday? - Novo Nordisk (NYSE:NVO)
Read More

What’s Going On With Novo Nordisk Stock Thursday? – Novo Nordisk (NYSE:NVO)

  • April 27, 2026
Oral Semaglutide Shows Superior Glycaemic Control The phase 3a study evaluated oral semaglutide in patients aged 10–17 years…
HHealthcare
Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake - Eli Lilly (NYSE:LLY)
Read More

Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake – Eli Lilly (NYSE:LLY)

  • April 18, 2026
Early Prescription Trends Show Slower Start For Lilly Reuters, citing IQVIA data, reported that Eli Lilly recorded 1,390…
HHealthcare
Eli Lilly Just Launched Its $149 Obesity Pill - Eli Lilly (NYSE:LLY)
Read More

Eli Lilly Just Launched Its $149 Obesity Pill – Eli Lilly (NYSE:LLY)

  • April 13, 2026
Eli Lilly and Co. (NYSE:LLY) on Wednesday announced that Foundayo (orforglipron) is now available to adults with obesity…
MMedication
Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic - Novo Nordisk (NYSE:NVO)
Read More

Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic – Novo Nordisk (NYSE:NVO)

  • January 31, 2026
Novo Nordisk A/S (NYSE:NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a…
PPersonal finance
Debt Can Ruin Your Life, Buffett Warns: 'Many People Love Spending Beyond Their Income'
Read More

Debt Can Ruin Your Life, Buffett Warns: ‘Many People Love Spending Beyond Their Income’

  • January 27, 2026
In a recent interaction renowned investor Warren Buffett offered advice on personal debt, parenting, and career selection. Buffett cautioned against the…
AArtificial intelligence
What's Going On With Alibaba Stock Monday? - Alibaba Gr Hldgs (NYSE:BABA)
Read More

What’s Going On With Alibaba Stock Monday? – Alibaba Gr Hldgs (NYSE:BABA)

  • January 13, 2026
Alibaba Group Holding Ltd (NYSE:BABA) is drawing renewed investor attention as momentum builds across its artificial intelligence ecosystem.…
HHealthcare
Oracle’s Secret AI Weapon: A Health Care Data Advantage Rivals Can't Replicate - Oracle (NYSE:ORCL)
Read More

Oracle’s Secret AI Weapon: A Health Care Data Advantage Rivals Can’t Replicate – Oracle (NYSE:ORCL)

  • December 10, 2025
Oracle Corp’s (NYSE:ORCL) earnings tonight will focus on cloud bookings, AI partnerships and GPU capacity — but the…
HHealthcare
AI Bubble Fear? This Sector Is Quietly Surging While Tech Sinks - Amgen (NASDAQ:AMGN), Bristol-Myers Squibb (NYSE:BMY)
Read More

AI Bubble Fear? This Sector Is Quietly Surging While Tech Sinks – Amgen (NASDAQ:AMGN), Bristol-Myers Squibb (NYSE:BMY)

  • November 15, 2025
It hasn’t been an easy stretch for technology and AI stocks, with triple-digit year-to-date gainers like Palantir Technologies…
HHealthcare
Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker - Novo Nordisk (NYSE:NVO)
Read More

Novo Nordisk’s $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker – Novo Nordisk (NYSE:NVO)

  • November 12, 2025
In a presentation at the American Heart Association’s (AHA’s) 2025 Scientific Sessions, researchers on Tuesday shared data from…
HHealthcare
Trump-Pfizer Deal Pushes Health Care To Best Rally In 5 Years - Agilent Technologies (NYSE:A), Biogen (NASDAQ:BIIB)
Read More

Trump-Pfizer Deal Pushes Health Care To Best Rally In 5 Years – Agilent Technologies (NYSE:A), Biogen (NASDAQ:BIIB)

  • October 2, 2025
Investors cheered a breakthrough drug pricing agreement between President Donald Trump and Pfizer Inc. (NYSE:PFE), sparking a sector-wide…
Israel News Beep | NewsBeep.com
www.newsbeep.com